Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.